Case Study: Pharmaceutical companies and Access to Medicine A case study for the Dutch Fair Insurance Guide

First Page		Document Content
Date: 2015-03-05 04:42:47 Economy Finance Money Pharmaceutical industry SNS Reaal Access to Medicine Index Insurance Achmea Allianz Pharmaceutical drug Investor		Case Study: Pharmaceutical companies and Access to Medicine A case study for the Dutch Fair Insurance Guide Add to Reading List Source URL: eerlijkegeldwijzer.nl Download Document from Source Website File Size: 1,42 MB Share Document on Facebook

	Case Study: Pharmaceutical companies and Access to Medicine A case study for the Dutch Fair Insurance Guide DocID: 1qRml - View Document
	Circulation: Area of Clip: Page 1 of 1 Irish Medical News* Tuesday, 29 September 2015 DocID: 1qM5g - View Document
	Intellectual Property and Access to Essential Medicines: A Tenuous Link? Calvin W.L. Ho, Klaus M. Leisinger Asian Bioethics Review, Volume 5, Issue 4, December 2013, ppArticle) DocID: 1oFCC - View Document
	Access to Medicine Foundation The Access to Medicine Index 2014 Improving maternal health and access to contraceptives: pharmaceutical companies’ DocID: 1gEB8 - View Document
	Investor Statement Access to Medicine Index The goal of investors is to create long-term shareholder value in the companies in which they invest. This potential is maximized by investing in well-managed, high quality DocID: 1eTGR - View Document